Simultaneous Immobilization of Bioactives During 3D Powder Printing of Bioceramic Drug‐Release Matrices

Advanced Functional Materials (Impact Factor: 10.44). 05/2010; 20(10):1585 - 1591. DOI: 10.1002/adfm.200901759

ABSTRACT The combination of a degradable bioceramic scaffold and a drug-delivery system in a single low temperature fabrication step is attractive for the reconstruction of bone defects. The production of calcium phosphate scaffolds by a multijet 3D printing system enables localized deposition of biologically active drugs and proteins with a spatial resolution of approximately 300 µm. In addition, homogeneous or localized polymer incorporation during printing with HPMC or chitosan hydrochloride allows the drug release kinetics to be retarded from first to zero order over a period of 3–4 days with release rates in the range 0.68%–0.96% h−1. The reduction in biological activity of vancomycin, heparin, and rhBMP-2 following spraying through the ink jet nozzles is between 1% and 18%. For vancomycin, a further loss of biological activity following incorporation into a cement and subsequent in vitro release is 11%. While previously acknowledged as theoretically feasible, is its shown for the first time that bone grafts with simultaneous geometry, localized organic bioactive loading, and localized diffusion control are a physical reality. This breakthrough offers a new future for patients by providing the required material function to match patient bone health status, site of repair, and age.


Available from: Elke Vorndran, May 03, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This work presents the tuning of drug-loaded scaffolds for bone regeneration as dual-drug delivery systems. Two therapeutic substances, zoledronic acid (anti-osteoporotic drug) and ibuprofen (anti-inflammatory drug) were successfully incorporated in a controlled manner into three dimensional designed porous scaffolds of apatite/agarose composite. A high-performance liquid chromatography method was optimized to separate and simultaneously quantify the two drugs released from the dual-drug codelivery system. The multifunctional porous scaffolds fabricated show a very rapid delivery of anti-inflammatory (interesting to reduce inflammation after implantation), whereas the anti-osteoporotic drug showed sustained release behaviour (important to promote bone regeneration). Since ibuprofen release was faster than desired, this drug was encapsulated in chitosan spheres which were then incorporated into the scaffolds, obtaining a release profile suitable for clinical application. The results obtained open the possibility to simultaneously incorporate two or more drugs to an osseous implant in a controlled way improving it for bone healing application. Copyright © 2015. Published by Elsevier B.V.
    International Journal of Pharmaceutics 03/2015; DOI:10.1016/j.ijpharm.2015.03.048 · 3.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Many researchers have attempted to use computer-aided design (CAD) and computer-aided manufacturing (CAM) to realize a scaffold that provides a three-dimensional (3D) environment for regeneration of tissues and organs. As a result, several 3D printing technologies, including stereolithography, deposition modeling, inkjet-based printing and selective laser sintering have been developed. Because these 3D printing technologies use computers for design and fabrication, have they can fabricate 3D scaffolds as designed; as a consequence, they can be standardized. Growth of target tissues and organs requires the presence of appropriate growth factors, so fabrication of 3Dscaffold systems that release these biomolecules has been explored. A drug delivery system (DDS) that administrates a pharmaceutical compound to achieve a therapeutic effect in cells, animals and humans is a key technology that delivers biomolecules without side effects caused by excessive doses. 3D printing technologies and DDSs have been assembled successfully, so new possibilities for improved tissue regeneration have been suggested. If the interaction between cells and scaffold system with biomolecules can be understood and controlled, and if an optimal 3D tissue regenerating environment is realized, 3D printing technologies will become an important aspect of tissue engineering research in the near future.
    Current Pharmaceutical Design 01/2015; 21(999). DOI:10.2174/1381612821666150115125324 · 3.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Three-dimensional powder printing (3DP) is attractive for the direct fabrication of bioceramic implants and scaffolds from a computer aided design file for bone tissue engineering by localized deposition of a reactive binder liquid onto thin powder layers. This article reviews recent findings on novel material developments for the three-dimensional (3D) printing process using either sintering regimes or cement setting reactions. Customized ceramic implants can be fabricated by 3DP using computer tomography data obtained from a patient, whereas further drug modification of such implants can be achieved either in situ or post-printing. The excellent biological in vitro and in vivo behavior of 3D-printed bioceramics together with processing at ambient conditions may give the opportunity to directly produce cell-seeded patient-specific implants for accelerated and enhanced bone regeneration in the future.
    MRS Bulletin 02/2015; 40(2):127. DOI:10.1557/mrs.2015.326 · 5.07 Impact Factor